Academic 2015-96: There are racial and gender differences in AF treatment

Academic 2015-96: AF Treatment Racial and Gender Differences2015-04-18 Great Wall International Conference of Cardiology
Great Wall International Conference of Cardiology
the Great Wall International Conference of Cardiologymicro-signalgwiccorgfeaturesmoment Learn the latest news and academic informationof the Great Wall International Cardiology Conference
(Original) Race and Gender Related In Care for The Patient Diagnoed with Atrial Fibrillation
BackgroundAtrial Fibrillation (AF) i aociated withincreaedd rik of troke and deathUniform utilization of the arterapie for AF may help reduce thoe rik.
Objective We to want to want to want to bed adhcant race and gender gu's off-the-people in the treatment of the newly diagnoed af indare Medicare beneficiarie.
Method We ued adminit encounter data for Medicare beneficiarie to identify patient newydd dignoed AF hefyd 2010-2011Service after initial af diagnoi hadd, lein viit with a cardiologit or electroiiologit, catabliologit, and ue of oral anticoagulant, rate agent, and and anti-ar.
Reult Overall, 517,941 patient met tudy, 452,986 (87%) was white, 36,425 (7%) was black, and 28,530 (6%) WasHipanicMale compried 41% of the cohortIn multivariate analyi, therewasa tatitly cant ant by-both race and gender in the ueof AF-yn ervice, with white patient and male patient patient patient themot careThe mot diparitie was for the white (Hipanic vwhite: Adjuted Hazard Ratio (AHR) 0.70, 95% CI 0.63-0.79, p 0.001; femalev male: AHR 0.65, 95% CI 0.63-0.68, p 0.001) and of the oralanticoagulation (black v white: AHR 0.94, 95% CI 0.92-0.001; Hipanicv white: AHR 0.94, 95% CI 0.93-0.97, p 0.001; female v male: AHR 0.93, 95% CI 0.93-0.94, p 0.001)Concluion Race andThe Gender-to-Body have-a-head hash-had-on-the-health care care provided to thi cohort of the patient sicPoible inge ei seilean in acce, patient preference, treatment bia, and unmeauredclinical characteritic.
Source: ACC CV New Diget (April 11, 2015)A recent cohort studyaf treatment for racial and gender differences (Chinese summary) showed that race and gender appear to have a significant impact on the treatment of patients with atrial fibrillation (AF), possible for reasons including racial differences in access to treatment, patient preferences, treatment bias, and untested clinical characteristics 　　AF is associated with an increased risk of stroke and death, and proper treatment may help reduce these risks The study used Medicare beneficiary management data to identify patients newly diagnosed with AF from 2010-2011 and was treated according to visits to cardiologists or electrophysiologists, catheter ablation, and oral anticoagulants, heart rate-control drugs, and anti-arrhythmia results showed that a total of 517,941 patients met the study criteria, with whites, blacks and Hispanics accounting for 87 percent, 7 percent and 6 percent, respectively, and 41 percent of men Multivariate analysis showed significant differences in race and gender access to AF-related medical services, with white and male patients receiving the most treatment The most significant differences are catheter ablation (Hispanic vs White: corrected HR: 0.70, P 0.001; female vs males: corrected HR: 0.65, P 0.001) and oral anticoagulant use (blacks vs whites: after correction HR: 0.94, P 0.001; Hispanicvs White: Corrected HR: 0.94, P 0.001; Female Vs Men: Corrected HR: 0.93, P 0.001)